Skip to content

Evaluation Of Clinical Results And Imaging Of Anterior Cruciate Ligament Reconstruction With Orthopure Xt

Evaluation Of Clinical Results And Imaging Of Anterior Cruciate Ligament Reconstruction With Orthopure Xt

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06091488
Enrollment
10
Registered
2023-10-19
Start date
2022-04-12
Completion date
2025-08-25
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL, ACL Injury

Brief summary

The purpose of this study is to evaluate subjective and objective clinical outcomes and imaging data of subjects undergoing reconstruction or revision of LCA reconstruction using OrthoPure XT

Interventions

OTHEROrthopure

Reconstruction of the anterior cruciate ligament of the knee in the patient.

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients between the ages of 18 and 65 at the time of ACL reconstruction surgery; * Patients aged 35 to 65 at the time of primary ACL reconstruction surgery; * Male and female sex; * First injury of the ACL with impossibility of use of autograft (patellar tendinopathy, quadriceps tendinopathy, goose leg tendinopathy) or refusal to use allograft (Bank tendon); * Recurrence of ACL injury with impossibility of use of autograft (prior use/tendinopathy of the patellar, previous use/tendinopathy of the quadriceps, previous use/tendinopathy of the goose leg) or refusal to use allograft (tendon of Bank);

Exclusion criteria

* Patients who do not consent to be included in the study * Presence of haematological, rheumatic or haemorrhagic disease time of assessment * ACL primary reconstruction in subjects under 35 * Allergies and/or reactions from hypersensitivity or religious objection to the use of porcine derivation * Pregnant and/or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
International Knee Documentation CommitteeAt baseline (day 0)The score goes from 0 to 100 where the maximum is 100 and expresses the absence of limitations and symptoms, and therefore an excellent result; the further you go from this score and the worse the result, which can therefore be divided into four groups: excellent (80-100)good (60-80), good (30-60), bad (0-30)
Lysholm Knee ScoreAt baseline (day 0)The final score is obtained from the sum of the various scores obtained in the different and ranges from 0 to 100. Scores are divided into subgroups: Excellent (95-100); Good (84-94); Decent (65-83); Poor (\<64).
Visual Analogue ScaleAt baseline (day 0)is a one-dimensional quantitative pain assessment scale at 10 points; the scale requires the patient to select the number that best describes the intensity of his pain, from 0 to 10, at that precise moment. 0 means no pain and 10 indicates the worst possible pain.
Tegner ScoreAt baseline (day 0)allows to estimate the level of motor activity of a subject with a score between 0 and 10, where 0 represents 'inability' and 10 represents 'participation in competitive sports
continuity of the graftAfter 24 monthsassess the continuity of the graft with magnetic resonance imaging

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026